The United Nations has recently come under attack for its handling of both the Ebola outbreak and the war in Syria. It has prompted some to question what the role of the U.N. should be on the international stage. We look at the relevance of the U.N., 70 years after its creation.
Guest Host: Steve Roberts
Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.
- Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Marc Kaufman reporter on the national desk of "The Washington Post"
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
Most Recent Shows
Many doctors support Angelina Jolie's decision to have her ovaries removed two years after a preventive double mastectomy. We explore testing for BRCA genetic mutations and debate over surgery to reduce cancer risks.
For this month's Readers' Review: "All The Light We Cannot See" by Anthony Doerr. The 2014 novel weaves together the stories of a blind French girl and a German orphan during World War II.
Nearly 10,000 U.S. military personnel remain in Afghanistan after combat forces withdrew last year. We explore a meeting between U.S. and Afghan officials this week, prospects for Congressional approval of additional troops and the future of security in the region.